Alpine Woods Capital Investors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.79M | Buy |
31,234
+2,190
| +8% | +$486K | 1.63% | 13 |
|
|
2025
Q4 | $6.64M | Sell |
29,044
-5,985
| -17% | -$1.36M | 1.58% | 13 |
|
|
2025
Q3 | $8.11M | Sell |
35,029
-374
| -1% | -$76.2K | 1.89% | 10 |
|
|
2025
Q2 | $6.57M | Buy |
35,403
+642
| +2% | +$119K | 1.56% | 16 |
|
|
2025
Q1 | $7.28M | Sell |
34,761
-8,732
| -20% | -$1.7M | 1.83% | 11 |
|
|
2024
Q4 | $7.73M | Buy |
43,493
+10,050
| +30% | +$1.85M | 1.46% | 14 |
|
|
2024
Q3 | $5.83M | Buy |
33,443
+4,282
| +15% | +$799K | 1.02% | 33 |
|
|
2024
Q2 | $5M | Sell |
29,161
-155
| -0.5% | -$25.7K | 0.77% | 44 |
|
|
2024
Q1 | $4.77M | Sell |
29,316
-23,107
| -44% | -$3.98M | 0.95% | 32 |
|
|
2023
Q4 | $8.12M | Sell |
52,423
-275
| -0.5% | -$40.1K | 1.21% | 22 |
|
|
2023
Q3 | $7.86M | Sell |
52,698
-1,948
| -4% | -$286K | 1.27% | 23 |
|
|
2023
Q2 | $7.36M | Sell |
54,646
-15,358
| -22% | -$2.25M | 1.15% | 26 |
|
|
2023
Q1 | $11.2M | Sell |
70,004
-4,374
| -6% | -$669K | 1.69% | 10 |
|
|
2022
Q4 | $12M | Buy |
74,378
+12,159
| +20% | +$1.86M | 1.75% | 13 |
|
|
2022
Q3 | $8.35M | Buy |
62,219
+3,426
| +6% | +$492K | 1.14% | 26 |
|
|
2022
Q2 | $9.01M | Sell |
58,793
-190
| -0.3% | -$29K | 1.13% | 27 |
|
|
2022
Q1 | $9.56M | Sell |
58,983
-9,470
| -14% | -$1.38M | 1.01% | 29 |
|
|
2021
Q4 | $9.27M | Sell |
68,453
-1,231
| -2% | -$145K | 0.92% | 31 |
|
|
2021
Q3 | $7.52M | Buy |
69,684
+3,494
| +5% | +$399K | 0.8% | 41 |
|
|
2021
Q2 | $7.46M | Sell |
66,190
-7
| -0% | -$788 | 0.77% | 43 |
|
|
2021
Q1 | $7.16M | Buy |
66,197
+4,906
| +8% | +$525K | 0.79% | 39 |
|
|
2020
Q4 | $6.57M | Buy |
61,291
+24,462
| +66% | +$2.35M | 0.8% | 38 |
|
|
2020
Q3 | $3.23M | Buy |
36,829
+590
| +2% | +$55.5K | 0.49% | 71 |
|
|
2020
Q2 | $3.56M | Sell |
36,239
-2,030
| -5% | -$179K | 0.68% | 43 |
|
|
2020
Q1 | $2.92M | Hold |
38,269
| – | – | 0.65% | 37 |
|
|
2019
Q4 | $3.39M | Hold |
38,269
| – | – | 0.64% | 40 |
|
|
2019
Q3 | $2.9M | Sell |
38,269
-704
| -2% | -$48.3K | 0.53% | 39 |
|
|
2019
Q2 | $2.83M | Sell |
38,973
-500
| -1% | -$39.3K | 0.59% | 43 |
|
|
2019
Q1 | $3.18M | Sell |
39,473
-1,580
| -4% | -$129K | 0.69% | 31 |
|
|
2018
Q4 | $3.79M | Buy |
41,053
+6,270
| +18% | +$551K | 0.91% | 21 |
|
|
2018
Q3 | $3.29M | Hold |
34,783
| – | – | 0.68% | 37 |
|
|
2018
Q2 | $3.22M | Hold |
34,783
| – | – | 0.7% | 33 |
|
|
2018
Q1 | $3.29M | Hold |
34,783
| – | – | 0.17% | 142 |
|
|
2017
Q4 | $3.36M | Buy |
34,783
+3,000
| +9% | +$283K | 0.17% | 148 |
|
|
2017
Q3 | $2.82M | Hold |
31,783
| – | – | 0.14% | 155 |
|
|
2017
Q2 | $2.31M | Hold |
31,783
| – | – | 0.12% | 162 |
|
|
2017
Q1 | $2.07M | Sell |
31,783
-500
| -2% | -$31.4K | 0.11% | 174 |
|
|
2016
Q4 | $2.02M | Sell |
32,283
-150
| -0.5% | -$9.16K | 0.11% | 175 |
|
|
2016
Q3 | $2.04M | Hold |
32,433
| – | – | 0.11% | 178 |
|
|
2016
Q2 | $2.01M | Sell |
32,433
-200
| -0.6% | -$12.2K | 0.12% | 168 |
|
|
2016
Q1 | $1.86M | Hold |
32,633
| – | – | 0.11% | 171 |
|
|
2015
Q4 | $1.93M | Sell |
32,633
-1,800
| -5% | -$104K | 0.1% | 182 |
|
|
2015
Q3 | $1.87M | Buy |
34,433
+300
| +0.9% | +$19.5K | 0.1% | 194 |
|
|
2015
Q2 | $2.29M | Sell |
34,133
-400
| -1% | -$26.1K | 0.12% | 179 |
|
|
2015
Q1 | $2.02M | Sell |
34,533
-14,900
| -30% | -$900K | 0.1% | 188 |
|
|
2014
Q4 | $3.23M | Buy |
49,433
+150
| +0.3% | +$9.46K | 0.17% | 137 |
|
|
2014
Q3 | $2.85M | Hold |
49,283
| – | – | 0.15% | 145 |
|
|
2014
Q2 | $2.78K | Buy |
49,283
+3,150
| +7% | +$165K | 0.07% | 133 |
|
|
2014
Q1 | $2.37M | Sell |
46,133
-250
| -0.5% | -$12.6K | 0.13% | 139 |
|
|
2013
Q4 | $2.45M | Buy |
46,383
+25,200
| +119% | +$1.24M | 0.14% | 138 |
|
|
2013
Q3 | $948K | Buy |
21,183
+150
| +0.7% | +$6.65K | 0.06% | 204 |
|
|
2013
Q2 | $869K | Buy |
+21,033
| New | +$920K | 0.06% | 198 |
|
Other funds holding ABBV
VCM
VPM
Alpine Woods Capital Investors's ABBV Position: Q1 2026 in Review
Alpine Woods Capital Investors increased its AbbVie (ABBV) stake by 7.5% in Q1 2026, buying an estimated $486K and bringing the position to 31,234 shares worth $6.79M. The position accounts for 1.63% of the portfolio, ranked #13.
Alpine Woods Capital Investors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $12M in Q4 2022. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Alpine Woods Capital Investors held 31,234 shares of AbbVie worth $6.79M as of Q1 2026.
- Alpine Woods Capital Investors bought 2,190 AbbVie shares in Q1 2026, an estimated $486K.
- AbbVie made up 1.63% of Alpine Woods Capital Investors's portfolio in Q1 2026, its #13 holding.
- Alpine Woods Capital Investors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Alpine Woods Capital Investors's AbbVie position peaked at $12M in Q4 2022.
- 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Alpine Woods Capital Investors's 13F filing for Q1 2026, filed 27 May 2026.